Nonresponse to adefovir : Host or virus dependent?SCHILDGEN, Oliver; HELM, Martin; GERLICH, Wolfram et al.Journal of clinical virology. 2006, Vol 37, Num 4, pp 327-328, issn 1386-6532, 2 p.Article

Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovirHUSSAIN, Munira; FUNG, Scott; LIBBRECHT, Evelien et al.Journal of clinical microbiology (Print). 2006, Vol 44, Num 3, pp 1094-1097, issn 0095-1137, 4 p.Article

Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infectionsDE CLERCQ, Erik.Clinical microbiology reviews (Print). 2003, Vol 16, Num 4, issn 0893-8512, 1, 569-596 [29 p.]Article

Factors Influencing Inadequate or Suboptimal Response to Adefovir With or Without Genotypic ResistanceXIA ZHOU; XUEMEI KUANG; KE FAN et al.Journal of medical virology. 2012, Vol 84, Num 7, pp 1030-1036, issn 0146-6615, 7 p.Article

Dynamics of Lamivudine-Resistant Hepatitis B Virus During Adefovir Monotherapy Versus Lamivudine Plus Adefovir Combination TherapyIJAZ, Samreen; ARNOLD, Catherine; DERVISEVIC, Samir et al.Journal of medical virology. 2008, Vol 80, Num 7, pp 1160-1170, issn 0146-6615, 11 p.Article

The current management of HBV drug resistanceLIAW, Yun-Fan.Journal of clinical virology. 2005, Vol 34, issn 1386-6532, S143-S146, SUP1Conference Paper

Successful treatment of an entecavir-resistant hepatitis B virus variantYATSUJI, Hiromi; HIRAGA, Nobuhiko; MAEKAWA, Toshiro et al.Journal of medical virology. 2007, Vol 79, Num 12, pp 1811-1817, issn 0146-6615, 7 p.Article

In vitro characterization of the anti-human cytomegalovirus activity of PMEA (Adefovir)XIONG, X; FLORES, C; FULLER, M. D et al.Antiviral research. 1997, Vol 36, Num 2, pp 131-137, issn 0166-3542Article

Hepatitis B e Antigen Predicts Delayed Reduction of HBV DNA Without Viral Breakthrough With Adefovir Dipivoxil and Lamivudine: A 5-Year Study of Patients With Hepatitis B With Lamivudine ResistanceIKEDA, Fusao; BABA, Nobuyuki; TAKAKI, Akinobu et al.Journal of medical virology. 2012, Vol 84, Num 10, pp 1562-1570, issn 0146-6615, 9 p.Article

Adefovir-Based Combination Therapy With Entecavir or Lamivudine for Patients With Entecavir-Refractory Chronic Hepatitis BSOON SUN KIM; JAE YOUN CHEONG; LEE, Dami et al.Journal of medical virology. 2012, Vol 84, Num 1, pp 18-25, issn 0146-6615, 8 p.Article

Efficacy of Adefovir Add-On Lamivudine Rescue Therapy Compared With Switching to Entecavir Monotherapy in Patients With Lamivudine-Resistant Chronic Hepatitis BHANJAKRYU; JUNGMINLEE; SANG HOONAHN et al.Journal of medical virology. 2010, Vol 82, Num 11, pp 1835-1842, issn 0146-6615, 8 p.Article

Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapySCHNEPF, Nathalie; SELLIER, Pierre; BENDENOUN, Marc et al.Journal of clinical virology. 2007, Vol 39, Num 1, pp 48-50, issn 1386-6532, 3 p.Article

Association of Intrahepatic cccDNA Reduction With the Improvement of Liver Histology in Chronic Hepatitis B Patients Receiving Oral Antiviral AgentsCHENG, Pin-Nan; LIU, Wen-Chun; TSAI, Hung-Wen et al.Journal of medical virology. 2011, Vol 83, Num 4, pp 602-607, issn 0146-6615, 6 p.Article

Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patientVILLENEUVE, Jean-Pierre; DURANTEL, David; ZOULIM, Fabien et al.Journal of hepatology. 2003, Vol 39, Num 6, pp 1085-1089, issn 0168-8278, 5 p.Article

Anti-human immunodeficiency virus (HIV) activity, safety, and pharmacokinetics of adefovir dipivoxil (9-[2-(bis-pivaloyloxymethyl)phosphonylmethoxyethyl]adenine) in HIV-infected patientsBARDITCH-CROVO, P; TOOLE, J; HENDRIX, C. W et al.The Journal of infectious diseases. 1997, Vol 176, Num 2, pp 406-413, issn 0022-1899Article

Anti-HIV activity of adefovir (PMEA) and PMPA in combination with antiretroviral compounds : in vitro analysesMULATO, A. S; CHERRINGTON, J. M.Antiviral research. 1997, Vol 36, Num 2, pp 91-97, issn 0166-3542Article

A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients with stringent cessation criteria for adefovirMINGHAO HA; GUOTONG ZHANG; ZHONGMING HUANG et al.Archives of virology. 2012, Vol 157, Num 2, pp 285-290, issn 0304-8608, 6 p.Article

Favourable outcome of adefovir-dipivoxil treatment in acute de novo hepatitis B after liver transplantationTONIUTTO, Pierluigi; FUMO, Elisabetta; CALDATO, Maja et al.Transplantation. 2004, Vol 77, Num 3, pp 472-473, issn 0041-1337, 2 p.Article

Effect of carbonate salts on the kinetics of acid-catalyzed dimerization of adefovir dipivoxilYUAN, Lung-Chi; DAHL, Terrence C; OLIYAI, Reza et al.Pharmaceutical research. 2000, Vol 17, Num 9, pp 1098-1103, issn 0724-8741Article

Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virusBARCENA, R; DEL CAMPO, S; OTERO, A et al.Transplantation proceedings. 2005, Vol 37, Num 9, pp 3960-3962, issn 0041-1345, 3 p.Conference Paper

Pharmacokinetics and metabolism of selected prodrugs of PMEA in ratsSHAW, J.-P; LOUIE, M. S; KRISHNAMURTHY, V. V et al.Drug metabolism and disposition. 1997, Vol 25, Num 3, pp 362-366, issn 0090-9556Article

Résistance précoce à l'adéfovir lors du traitement d'une hépatite B chronique = Early resistance to adefovir during treatment of a chronic hepatitis BGAUDY, C; SI-AHMED, S. N; BUSSEREAU, J et al.Virologie (Montrouge). 2006, Vol 10, Num 2, pp 143-145, issn 1267-8694, 3 p.Article

Phenotyping hepatitis B virus variants : From transfection towards a small animal in vivo infection modelNASSAL, Michael; DALLMEIER, Kai; SCHULTZ, Ursula et al.Journal of clinical virology. 2005, Vol 34, issn 1386-6532, S89-S95, SUP1Conference Paper

Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis BWESTLAND, Christopher E; HUILING YANG; DELANEY, William E et al.Hepatology (Baltimore, Md.). 2003, Vol 38, Num 1, pp 96-103, issn 0270-9139, 8 p.Article

Herpes simplex virus isolates with reduced adefovir susceptibility selected in vivo by foscarnet therapyBESTMAN-SMITH, Julie; BOIVIN, Guy.Journal of medical virology. 2002, Vol 67, Num 1, pp 88-91, issn 0146-6615Article